Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids

R. Fonte(Istituto Tumori Bari), Amalia Azzariti(Istituto Tumori Bari)

Frontiers in Cell and Developmental Biology

June 13, 2023

10.3389/fcell.2023.1178316

Cited by 16

Related Papers

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

|Molecular Cancer|2022|147

Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination

|Hepatology|2016|102

The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study

|Scientific Reports|2020|36